Literature DB >> 9397158

Endothelial and serum factors which include apolipoprotein A1 tether elastin to smooth muscle cells inducing serine elastase activity via tyrosine kinase-mediated transcription and translation.

K Thompson1, J Kobayashi, T Childs, D Wigle, M Rabinovitch.   

Abstract

We previously reported that serine elastase activity is induced in cultured porcine pulmonary artery (PA) smooth muscle cells (SMC) following serum stimulation by a mechanism involving adhesion of elastin to an elastin binding protein and tyrosine kinase activity. The present study demonstrates that a PA endothelial cell factor also promotes a fourfold increase in elastin adhesion to PA SMC and a twofold increase in serine elastase activity. The mechanism involves tethering of the factor to SMC, since [3H]-elastin pre-incubated with serum or endothelial cell (EC)-conditioned medium or SMC pre-treated with serum accelerates binding of elastin and tyrosine-kinase related elastase activity. The serum factor appears to interact with integrins as elastase induction is partially inhibited by RGD peptides. The elastase-inducing properties of serum could not, however, be attributed to several RGD-containing proteins. While a 120 kD fibronectin fragment partially reproduced the effect, it was not found in the serum fraction containing elastase-inducing activity. Instead, a 27 kD serum protein was enriched by elastin affinity chromatography, identified as apolipoprotein (Apo) A1 by microsequence analysis, and found to have about 50% of the elastase-inducing activity of serum. Elastase induction is inhibited by actinomycin and cycloheximide, suggesting a requirement for mRNA transcription and protein synthesis. Our results suggest a novel cell-extracellular matrix interaction whereby a soluble factor, in this case a lipoprotein, binds and tethers a matrix component to the cell surface and induces tyrosine kinase-dependent transcription of mRNA culminating in substrate proteolysis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9397158     DOI: 10.1002/(SICI)1097-4652(199801)174:1<78::AID-JCP9>3.0.CO;2-D

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  5 in total

Review 1.  Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension.

Authors:  Marlene Rabinovitch; Christophe Guignabert; Marc Humbert; Mark R Nicolls
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

2.  Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease.

Authors:  K N Cowan; P L Jones; M Rabinovitch
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

3.  Key inflammatory pathways underlying vascular remodeling in pulmonary hypertension.

Authors:  E M Berghausen; L Feik; M Zierden; M Vantler; S Rosenkranz
Journal:  Herz       Date:  2019-04       Impact factor: 1.443

4.  Neutrophil elastase is produced by pulmonary artery smooth muscle cells and is linked to neointimal lesions.

Authors:  Yu-Mee Kim; Leila Haghighat; Edda Spiekerkoetter; Hirofumi Sawada; Cristina M Alvira; Lingli Wang; Swati Acharya; Gabriela Rodriguez-Colon; Andrew Orton; Mingming Zhao; Marlene Rabinovitch
Journal:  Am J Pathol       Date:  2011-07-19       Impact factor: 4.307

5.  Suppressed smooth muscle proliferation and inflammatory cell invasion after arterial injury in elafin-overexpressing mice.

Authors:  S H Zaidi; X M You; S Ciura; S O'Blenes; M Husain; M Rabinovitch
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.